Top compounds associated with response to SPRR1A


Feature Type Standardized
Nominal ANOVA
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.041 0.4
mRNA canertinib CTRPv2 pan-cancer AAC 0.032 0.4
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.032 0.4
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA Teniposide CTRPv2 pan-cancer AAC -0.033 0.4
mRNA WP1130 CTRPv2 pan-cancer AAC 0.031 0.4
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.031 0.4
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.031 0.4
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.033 0.4
Download CSV